Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2010-11-24 Transaction in Own Shar…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules and compliance statements related to a share buy-back program. It provides detailed information about the number of shares bought back, prices paid, and compliance with relevant regulations. The content is focused on reporting the company's share repurchase activity rather than announcing a new financing round or capital structure change. The document length is 2638 characters, which is relatively short but contains substantive data about the buy-back. According to the filing definitions, reports of the company buying back or selling its own shares fall under 'Transaction in Own Shares' (POS). Therefore, the appropriate classification is POS with high confidence.
2010-11-24 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules and daily reporting of shares bought back. It provides detailed information on the number of shares repurchased, prices paid, and compliance statements related to the buy-back program. The document is short (2638 characters) and focuses on daily share repurchase activity rather than a full financial report or announcement of a report. This matches the definition of a 'Transaction in Own Shares' filing, which reports on the company's buyback of its own shares. Therefore, the correct classification is POS (Transaction in Own Shares).
2010-11-23 English
Change to Company Details 6 pages ?Kb
Regulatory Filings
2010-11-22 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules related to share buy-backs. It provides detailed information about the number of shares bought back, prices paid, compliance statements, and participation by directors. The document is short (2816 characters) and focuses on reporting daily share buy-back activity rather than announcing or discussing a broader financial report or capital raising. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. Therefore, the correct classification is POS (Transaction in Own Shares).
2010-11-21 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules related to share buy-backs. It provides detailed information about the number of shares bought back, prices paid, compliance statements, and participation by directors. The content is focused on reporting daily share repurchase activity rather than announcing a new share issue or capital change. The document length is 2638 characters, which is relatively short but contains substantive data about share buy-back transactions. This matches the description of a 'Transaction in Own Shares' filing, which reports on the company's buy-back of its own shares. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2010-11-18 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to securities issuance and quotation. It details the issuance of ordinary shares and performance rights, the terms of the securities, and the application for quotation on the ASX. The content is focused on announcing a new issue of shares and related securities, including details about the issue price, purpose, and quotation agreement. There are no financial statements or management discussion, nor is this a report or presentation. The document is a formal announcement of a capital raising event and securities issuance, consistent with a Capital/Financing Update filing. It is not a full financial report or earnings release, but a regulatory announcement about new securities issued and their quotation on the exchange.
2010-11-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.